BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35121883)

  • 1. IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy.
    Jacob Berger A; Gigi E; Kupershmidt L; Meir Z; Gavert N; Zwang Y; Prior A; Gilad S; Harush U; Haviv I; Stemmer SM; Blum G; Merquiol E; Mardamshina M; Kaminski Strauss S; Friedlander G; Bar J; Kamer I; Reizel Y; Geiger T; Pilpel Y; Levin Y; Tanay A; Barzel B; Reuveni H; Straussman R
    Nat Cancer; 2021 Oct; 2(10):1055-1070. PubMed ID: 35121883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation.
    Hançer NJ; Qiu W; Cherella C; Li Y; Copps KD; White MF
    J Biol Chem; 2014 May; 289(18):12467-84. PubMed ID: 24652289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRAS40 Phosphorylation Correlates with Insulin-Like Growth Factor-1 Receptor-Induced Resistance to Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells.
    Dougherty MI; Lehman CE; Spencer A; Mendez RE; David AP; Taniguchi LE; Wulfkuhle J; Petricoin EF; Gioeli D; Jameson MJ
    Mol Cancer Res; 2020 Sep; 18(9):1392-1401. PubMed ID: 32467173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.
    Jiang G; Dallas-Yang Q; Biswas S; Li Z; Zhang BB
    Biochem J; 2004 Jan; 377(Pt 2):339-46. PubMed ID: 14556646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer.
    Luo L; Zhang Z; Qiu N; Ling L; Jia X; Song Y; Li H; Li J; Lyu H; Liu H; He Z; Liu B; Zheng G
    Nat Commun; 2021 May; 12(1):2699. PubMed ID: 33976188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic destruction of insulin receptor substrates for cancer treatment.
    Reuveni H; Flashner-Abramson E; Steiner L; Makedonski K; Song R; Shir A; Herlyn M; Bar-Eli M; Levitzki A
    Cancer Res; 2013 Jul; 73(14):4383-94. PubMed ID: 23651636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.
    Kang S; Chemaly ER; Hajjar RJ; Lebeche D
    J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of both EGFR and IGF1R sensitized prostate cancer cells to radiation by synergistic suppression of DNA homologous recombination repair.
    Wang Y; Yuan JL; Zhang YT; Ma JJ; Xu P; Shi CH; Zhang W; Li YM; Fu Q; Zhu GF; Xue W; Lei YH; Gao JY; Wang JY; Shao C; Yi CG; Wang H
    PLoS One; 2013; 8(8):e68784. PubMed ID: 23950876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer.
    Raoof S; Mulford IJ; Frisco-Cabanos H; Nangia V; Timonina D; Labrot E; Hafeez N; Bilton SJ; Drier Y; Ji F; Greenberg M; Williams A; Kattermann K; Damon L; Sovath S; Rakiec DP; Korn JM; Ruddy DA; Benes CH; Hammerman PS; Piotrowska Z; Sequist LV; Niederst MJ; Barretina J; Engelman JA; Hata AN
    Oncogene; 2019 Sep; 38(37):6399-6413. PubMed ID: 31324888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LPIN1 promotes epithelial cell transformation and mammary tumourigenesis via enhancing insulin receptor substrate 1 stability.
    Kim JY; Kim G; Lim SC; Choi HS
    Carcinogenesis; 2016 Dec; 37(12):1199-1209. PubMed ID: 27729374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salicylic acid reverses phorbol 12-myristate-13-acetate (PMA)- and tumor necrosis factor alpha (TNFalpha)-induced insulin receptor substrate 1 (IRS1) serine 307 phosphorylation and insulin resistance in human embryonic kidney 293 (HEK293) cells.
    Jiang G; Dallas-Yang Q; Liu F; Moller DE; Zhang BB
    J Biol Chem; 2003 Jan; 278(1):180-6. PubMed ID: 12409308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin Receptor Substrate 1, the Hub Linking Follicle-stimulating Hormone to Phosphatidylinositol 3-Kinase Activation.
    Law NC; Hunzicker-Dunn ME
    J Biol Chem; 2016 Feb; 291(9):4547-60. PubMed ID: 26702053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2.
    Copps KD; White MF
    Diabetologia; 2012 Oct; 55(10):2565-2582. PubMed ID: 22869320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutant insulin receptor induces formation of a Shc-growth factor receptor bound protein 2 (Grb2) complex and p21ras-GTP without detectable interaction of insulin receptor substrate 1 (IRS1) with Grb2. Evidence for IRS1-independent p21ras-GTP formation.
    Ouwens DM; van der Zon GC; Pronk GJ; Bos JL; Möller W; Cheatham B; Kahn CR; Maassen JA
    J Biol Chem; 1994 Dec; 269(52):33116-22. PubMed ID: 7806540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the degradation determinants of insulin receptor substrate 1 for signaling cullin-RING E3 ubiquitin ligase 7-mediated ubiquitination.
    Xu X; Keshwani M; Meyer K; Sarikas A; Taylor S; Pan ZQ
    J Biol Chem; 2012 Nov; 287(48):40758-66. PubMed ID: 23045529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress.
    Potashnik R; Bloch-Damti A; Bashan N; Rudich A
    Diabetologia; 2003 May; 46(5):639-48. PubMed ID: 12750770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of IRS1 at serine 307 in response to insulin in human adipocytes is not likely to be catalyzed by p70 ribosomal S6 kinase.
    Rajan MR; Fagerholm S; Jönsson C; Kjølhede P; Turkina MV; Strålfors P
    PLoS One; 2013; 8(4):e59725. PubMed ID: 23565163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance.
    Knowlden JM; Jones HE; Barrow D; Gee JM; Nicholson RI; Hutcheson IR
    Breast Cancer Res Treat; 2008 Sep; 111(1):79-91. PubMed ID: 17902048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evodiamine inhibits insulin-stimulated mTOR-S6K activation and IRS1 serine phosphorylation in adipocytes and improves glucose tolerance in obese/diabetic mice.
    Wang T; Kusudo T; Takeuchi T; Yamashita Y; Kontani Y; Okamatsu Y; Saito M; Mori N; Yamashita H
    PLoS One; 2013; 8(12):e83264. PubMed ID: 24391749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrageenan Inhibits Insulin Signaling through GRB10-mediated Decrease in Tyr(P)-IRS1 and through Inflammation-induced Increase in Ser(P)307-IRS1.
    Bhattacharyya S; Feferman L; Tobacman JK
    J Biol Chem; 2015 Apr; 290(17):10764-74. PubMed ID: 25784556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.